Clinical Trials Directory

Trials / Completed

CompletedNCT00947323

Simvastatin for Treating Erectile Dysfunction

The Effect of Simvastatin in the Penile Erection: a Randomized, Double-blind Clinical Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
41 (actual)
Sponsor
Santa Casa de Porto Alegre · Academic / Other
Sex
Male
Age
35 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This is a randomized clinical trial, double-blind, placebo controlled, to verify if simvastatin can improve erectile dysfunction in men with endothelial dysfunction, without any cardiac disease.It is hypothesized that the simvastatin can improve the endothelial function, improving the nitric oxide liberation in corpora cavernosa of the penis, resulting in improvement of erection.

Conditions

Interventions

TypeNameDescription
DRUGSimvastatinsimvastatin 20 daily for six months.
DRUGPlacebo

Timeline

Start date
2006-01-01
Primary completion
2008-07-01
Completion
2008-12-01
First posted
2009-07-28
Last updated
2010-09-27

Source: ClinicalTrials.gov record NCT00947323. Inclusion in this directory is not an endorsement.

Simvastatin for Treating Erectile Dysfunction (NCT00947323) · Clinical Trials Directory